Empowering Patients,
Amplifying Voices
Developmental Epileptic Encephalopathies (DEE's) are many and varied, but the lives of affected families are similar.
We are resilient. We can plan for many outcomes and plan many alternate solutions for if and when those plans go awry.
We have been thoroughly frightened and have come back to celebrate someone's ability to smile.
We can cry together, worry together, and laugh together
(and nobody gets our humour like we do!).
If you are living with or know someone living with a DEE, please contact us, we'd love to have you join us on our journey together.
Individually, we are rare.
Together, we are mighty.
Tuberous sclerosis complex (TSC) is a genetic disorder that causes tumors to form in many different organs, primarily in the brain, eyes, heart, kidney, skin, and lungs. Despite its complexity, understanding this condition can be a source of hope, strength, and empowerment throughout life’s stages.
CHD2-related neurodevelopmental disorders are a group of seizure disorders that typically present in the first five years of life and may be characterized by refractory or drug-resistant epilepsy, developmental delays, and photosensitivity epilepsy caused by flashing lights. Other symptoms may include intellectual disability, autism spectrum disorders, neuropsychiatric conditions, low muscle tone, and challenging behaviors. The disorder is diagnosed by molecular genetic testing and treated with anti-seizure medication and therapies for autism, intellectual disabilities, and speech delays. The prevalence of CHD2 is unknown but it is thought to be underdiagnosed.
CDKL5 deficiency disorder is a rare developmental epileptic encephalopathy caused by mutations in the CDKL5 gene, and this can manifest in a broad range of clinical symptoms and severity. The hallmarks are early-onset, intractable epilepsy and neurodevelopmental delay impacting cognitive, motor, speech, and visual function. Although rare, the occurrence is believed to be ~1:40,000 -75,000 live births, making it one of the most common forms of genetic epilepsy.
SLC13A5 Epilepsy is a newly discovered disorder with many names. First described in July of 2014, SLC13A5 Epilepsy is a neurological disorder associated with the gene SLC13A5. This gene codes for a protein that is responsible for transporting citrate. Mutations in this gene cause epilepsy starting in the first few days of life and developmental problems.
MORE DEE's INCLUDE:
SCN8A
Doose Syndrome
West Syndrome
Ohtahara (EIDEE)
Landau-Kleffner syndrome
Some CDG's
CACNA1A (DEE42)
If you have a DEE, or know of someone with a DEE, or know of a DEE group who would like to join us, please contact us and let us know.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.